Osteoporosis and schizophrenia: Can we limit known risk factors?
- 1 July 1995
- journal article
- other
- Published by Elsevier in Biological Psychiatry
- Vol. 38 (2) , 131-132
- https://doi.org/10.1016/0006-3223(95)00062-l
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clozapine decreases smoking in patients with chronic schizophreniaBiological Psychiatry, 1995
- Treatment of Polydipsia and Hyponatremia in Psychiatric PatientsNeuropsychopharmacology, 1995
- Schizophrenia and smoking: an epidemiological survey in a state hospitalAmerican Journal of Psychiatry, 1995
- Physical comorbidity and polypharmacy in older psychiatric patientsBiological Psychiatry, 1994
- Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazineBiological Psychiatry, 1994
- Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literatureBiological Psychiatry, 1994
- Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsiaBiological Psychiatry, 1989
- Osteoporosis in Men with Hyperprolactinemic HypogonadismAnnals of Internal Medicine, 1986
- Decreased Bone Density in Hyperprolactinemic WomenNew England Journal of Medicine, 1980